Condition: Stem Cell Transplant Complications · Sponsor: AHS Cancer Control Alberta
The research question for the current study is: Is loratadine more effective than placebo in preventing G-CSF-related bone pain during autologous hematopoetic stem cell transplant in patients with lymphoma or multiple myeloma? The hypothesis is that prophylaxis with loratadine will help prevent or reduce the severity of bone pain in this setting.
This description comes directly from the study's public registry record.
Michael Chu, MD · 780-432-8757 · Michael.Chu@ahs.ca
Rammy Khadour · 780-432-8795 · Rammy.Khadour@ahs.ca
Always discuss trial participation with your own doctor first.
| Cross Cancer Institute | Edmonton, Alberta, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05421416